Acetyl Octapeptide-3
CosmeticCosmetic SNARE-targeting peptideExperimental
Elongated Argireline analog (SNAP-8) used in topical cosmetics. Not an FDA-approved drug; not WADA-prohibited as a cosmetic peptide.
For research use only.
Key Facts
- CAS
- 868844-74-0
- Molecular Weight (MW)
- ≈1075.2 g/mol
- Half-life
- Topical; systemic PK not established
- Unit
- mcg
- Administration Route
- Topical
- Frequency
- —
- Last updated
- 8/23/2026
- Targets
- SNAP-25 / SNARE complex
Overview
Elongated Argireline analog (SNAP-8) used in topical cosmetics. Not an FDA-approved drug; not WADA-prohibited as a cosmetic peptide.
Protocol
- Dosage Range
- Per cosmetic formulation
- Frequency
- —
- Cycle
- —
- Administration Route
- Topical
- Reconstitution Guide
- —
Science
Mechanism of Action
SNAP-25 mimetic octapeptide designed to reduce SNARE-mediated neurotransmitter vesicle fusion in model systems, with topical cosmetic use for expression lines.
Targets
SNAP-25 / SNARE complex
Studies
- SNAP-8 cosmetic peptide literature— Journal/year not available
Benefits
Topical wrinkle-care researchPairs with acetyl hexapeptide-8 in cosmetics
Potential Side Effects
- Mild irritation
- Redness
References
- INCI / PubChem SNAP-8External link · Year —